[go: up one dir, main page]

AU2016425935B2 - Method for the management of dysmenorrhea and menstrual pain - Google Patents

Method for the management of dysmenorrhea and menstrual pain Download PDF

Info

Publication number
AU2016425935B2
AU2016425935B2 AU2016425935A AU2016425935A AU2016425935B2 AU 2016425935 B2 AU2016425935 B2 AU 2016425935B2 AU 2016425935 A AU2016425935 A AU 2016425935A AU 2016425935 A AU2016425935 A AU 2016425935A AU 2016425935 B2 AU2016425935 B2 AU 2016425935B2
Authority
AU
Australia
Prior art keywords
component
estetrol
dysmenorrhea
administration
progestogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016425935A
Other languages
English (en)
Other versions
AU2016425935A1 (en
Inventor
Maud JOST
Glwadys RAUSIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Estetra SRL
Original Assignee
Estetra SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Estetra SRL filed Critical Estetra SRL
Publication of AU2016425935A1 publication Critical patent/AU2016425935A1/en
Assigned to ESTETRA SRL reassignment ESTETRA SRL Amend patent request/document other than specification (104) Assignors: ESTETRA SPRL
Priority to AU2022231672A priority Critical patent/AU2022231672B2/en
Application granted granted Critical
Publication of AU2016425935B2 publication Critical patent/AU2016425935B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2016425935A 2016-08-05 2016-10-28 Method for the management of dysmenorrhea and menstrual pain Active AU2016425935B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2022231672A AU2022231672B2 (en) 2016-08-05 2022-09-13 Method for the management of dysmenorrhea and menstrual pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2016/076104 WO2018065076A1 (fr) 2016-10-28 2016-10-28 Méthode de prise en charge de la dysménorrhée et des douleurs menstruelles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2022231672A Division AU2022231672B2 (en) 2016-08-05 2022-09-13 Method for the management of dysmenorrhea and menstrual pain

Publications (2)

Publication Number Publication Date
AU2016425935A1 AU2016425935A1 (en) 2019-05-16
AU2016425935B2 true AU2016425935B2 (en) 2023-01-19

Family

ID=57209484

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016425935A Active AU2016425935B2 (en) 2016-08-05 2016-10-28 Method for the management of dysmenorrhea and menstrual pain

Country Status (6)

Country Link
JP (1) JP2018533542A (fr)
KR (1) KR102780201B1 (fr)
AU (1) AU2016425935B2 (fr)
CA (1) CA3041016C (fr)
MY (1) MY205032A (fr)
WO (1) WO2018065076A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (fr) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Procédé de préparation d'estetrol
NZ737948A (en) 2015-06-18 2023-03-31 Estetra Sprl Orodispersible dosage unit containing an estetrol component
KR102662025B1 (ko) 2015-06-18 2024-05-02 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 에스테트롤 성분을 함유하는 구강분해성 투여 단위
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CA3178291A1 (fr) 2016-08-05 2018-04-12 Estetra Srl Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles
MA51733A (fr) 2018-02-07 2020-12-16 Estetra Sprl Composition contraceptive présentant des effets cardiovasculaires réduits
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) * 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
HU231240B1 (hu) 2019-09-03 2022-04-28 Richter Gedeon Nyrt. Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására
IT202000003964A1 (it) * 2020-02-26 2021-08-26 Umberto Cornelli Composizione farmaceutica per l’uso nel trattamento di dismenorrea e/o sindrome premestruale
TWI893101B (zh) * 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
WO2022166599A1 (fr) * 2021-02-02 2022-08-11 广州沪同有梧生物科技有限公司 Nouvelle utilisation de pqq et de son dérivé
HUP2400151A1 (hu) 2024-02-28 2025-09-28 Richter Gedeon Nyrt Ösztetrol-monohidrát kristályosítási eljárás

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012055840A1 (fr) * 2010-10-28 2012-05-03 Bayer Pharma Aktiengesellschaft Composition et préparation pour le traitement de la dysménorrhée et de la douleur menstruelle et utilisation d'un agent hormonal et d'un sel de zinc pour le traitement de troubles menstruels
WO2018024912A1 (fr) * 2016-08-05 2018-02-08 Estetra Sprl Méthode de gestion de la dysménorrhée et de la douleur menstruelle.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344405C2 (de) 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012055840A1 (fr) * 2010-10-28 2012-05-03 Bayer Pharma Aktiengesellschaft Composition et préparation pour le traitement de la dysménorrhée et de la douleur menstruelle et utilisation d'un agent hormonal et d'un sel de zinc pour le traitement de troubles menstruels
WO2018024912A1 (fr) * 2016-08-05 2018-02-08 Estetra Sprl Méthode de gestion de la dysménorrhée et de la douleur menstruelle.

Also Published As

Publication number Publication date
AU2016425935A1 (en) 2019-05-16
MY205032A (en) 2024-09-28
KR20190076014A (ko) 2019-07-01
WO2018065076A1 (fr) 2018-04-12
CA3041016A1 (fr) 2018-04-12
JP2018533542A (ja) 2018-11-15
CA3041016C (fr) 2023-09-05
KR102780201B1 (ko) 2025-03-12

Similar Documents

Publication Publication Date Title
AU2022231672B2 (en) Method for the management of dysmenorrhea and menstrual pain
AU2016425935B2 (en) Method for the management of dysmenorrhea and menstrual pain
US20200046729A1 (en) Methods using combined oral contraceptive compositions with reduced cardiovascular effects
RU2169567C2 (ru) Способ контрацепции женщин репродуктивного возраста, не достигших предменопаузы
JP7651645B2 (ja) 心臓血管系への影響を低減した避妊薬組成物
KR101812160B1 (ko) 연장된 호르몬성 피임제 투약법에서 파탄성 출혈의 관리
NZ262657A (en) Hormone replacement therapy using estrogen and antiprogestin
EP1796725B1 (fr) Traitement ou prevention des hemorragies occasionnelles chez les femmes sous progestogenotherapie
US20250360147A1 (en) Methods using combined oral contraceptive compositions with reduced cardiovascular effects
EP1462107A1 (fr) Weibliches Empfängnisverhutungmethode und pharmazeutische Zuberaitungen die für eine solche Methode geeignet sind
JPH08508502A (ja) 骨粗しょう症の治療方法および治療用組成物
JP2008527018A (ja) 避妊用医薬製剤
US20080280861A1 (en) Method of Female Contraception and a Kit For Use Therein
Contraception Section 4 Contraception
HK1112200A (en) Contraceptive pharmaceutical preparation

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: ESTETRA SRL

Free format text: FORMER NAME(S): ESTETRA SPRL

FGA Letters patent sealed or granted (standard patent)